Approval · Notice of Compliance 34760 · 2025
PREGABALIN: Notice of Compliance 34760
Issued January 30, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34760
- Date
- January 30, 2025
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers. Administrative: Update to labelling (to match Licensor)
- Canadian reference product
- LYRICA (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREGABALIN | Not yet assigned | — |
| PREGABALIN | 02555085 | Approved |
Medicinal ingredients
- PREGABALIN 25 MG per CAP
- PREGABALIN 50 MG per CAP
- PREGABALIN 75 MG per CAP
- PREGABALIN 150 MG per CAP
- PREGABALIN 225 MG per CAP
- PREGABALIN 300 MG per CAP